Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
NCT05459688
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
175
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
CIN-107
Sponsor
AstraZeneca